Data from Pfizer indicates only 0.18% to 0.36% short term events are reported

Login or register to post comments Last Post 0 reads   6 posts
  • Wed, Oct 06, 2021 - 01:17pm

    #1
    SDHodges

    SDHodges

    Status Member (Offline)

    Joined: Jun 05 2021

    Posts: 39

    count placeholder9

    Data from Pfizer indicates only 0.18% to 0.36% short term events are reported

Following testing of booster jabs for Covid, Pfizer made some rather startling admissions about the true rates of adverse reactions in their more recent studies following second jabs for 18-55 year olds.

CNBC reports:

Side effects from Covid vaccine booster shots are similar to those felt after the second dose and are more likely to affect younger people, Pfizer said in new data submitted to the Food and Drug Administration as it seeks approval to distribute booster shots across the U.S.

Pfizer’s phase three study of vaccine booster doses, which included a group of about 300 participants from ages 18 to 55, found that 63.7% experienced fatigue after getting their boosters, 48.4% had headaches and 39.1% felt muscle pain. The majority of reactions to the booster were mild or moderate in severity, the company said in a 52-page report released by the agency Wednesday……Pfizer previously evaluated side effects on 2,682 second-dose recipients ages 16 to 55 and found that 61.5% developed fatigue, 54% suffered headaches and 39.3% dealt with muscle pain……16.4% of participants in the second dose study reported fever symptoms.

https://www.cnbc.com/2021/09/15/covid-boosters-pfizer-releases-new-data-showing-side-effects-are-similar-to-second-dose.html

That gives us a list of 4 adverse reactions and their frequency taken directly from Pfizer’s study of 2,682 second dose recipients.

Fatigue: 61.5%
Headaches: 54%
Muscle ache: 39.3%
Fever: 16.4%

For the booster shot, CNBC reports two additional reactions.

The report also found that 29.1% of booster recipients experienced chills, while 25.3% felt joint pain.

Given that Pfizer has stressed the similarity between the results of the two studies then we are entitled to take the figures for chills and joint pain to be also applicable to the second dose data which gives us a short list of 6 adverse reactions and their expected frequency.

Fatigue: 61.5%
Headache: 54%
Muscle ache: 39.3%
Fever: 16.4%
Chills: 29.1%
Joint Pain: 25.3%

All of this is deeply disturbing in that when fishing for an emergency use authorization from the FDA in November 2020, Pfizer gave an entirely different and much smaller set of figures covering just 2 side effects.

The only Grade 3 (severe) solicited adverse events greater than or equal to 2% in frequency after the first or second dose was fatigue at 3.8% and headache at 2.0% following dose 2.

https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine

I have not seen a single report anywhere in the MSM that refers to this glaring discrepancy.

UK Column news have set up a useful data analysis tool for MHRA yellow card data that allows us to see how many of these events have been entered into the system and how many doses of each vaccine have been given.

https://yellowcard.ukcolumn.org/yellow-card-reports

Up until the 24th September 2021, 19.4 million second doses of the Pfizer vaccine have been administered in the UK.  Given this is effectively a national scale clinical trial then had the UK established a very basic follow up protocol of telephoning the vaccine recipient 3 days after receiving their jab, then such a rudimentary protocol would have been expected to produce the following results to be consistent with Pfizer’s own research.

Against the 19.4 million second doses, I have listed the number of expected events based upon Pfizer’s data and then in brackets, placed the actual number recorded by the MHRA yellow card system along with the percentage of events ‘successfully’ captured.

11.9 million reports of fatigue (18,442 – 0.15%)
10.5 million reports of headache (22,074 – 0.2%)
7.6 million reports of muscle ache (9,037 – 0.12%)
3.2 million reports of fever (11,954 – 0.37%)
5.6 million reports of chills (7,581 – 0.14%)
4.9 million reports of joint pain (7,356 – 0.15%)

This gives us a total of over 43 million missing reports just for 6 specific side effects for one vaccine when only 330,983 reactions have been recorded for Pfizer in total and just 1.2 million for all vaccines and all possible events.  This shows in the worst case scenario less than 0.2% of adverse events are being reported and recorded.

Taken together there are 43.7 million events and just 76,444 report in the yellow card system for these six events giving an average of 0.17%.  Even if we said that only half of the 19.4 million were under 55 and those over 55 experienced no events whatsoever then that would still leave us with a reporting rate of just 0.34%.  Of course this entirely ignores all those events experienced after the first jab so 0.18% is still probably closer to the true picture.

What government would stand by an early warning air defence system that missed 99.8% of incoming enemy aircraft?  It seems clear from this that reporting of adverse events is being systemically suppressed and discouraged on every level.

I invite other readers to suggest precise reasons why this data is not being reported.  My first three suggestions are below.

Instead of reporting every event regardless of the underlying cause as should be the case in any clinical trial, healthcare professionals are routinely dismissing events as coincidental.

If events are on the list of expected events they are not being reported by vaccine recipients because they are already on the list and the authorities already know about them.

If events are reported to healthcare professionals and they are not on the list of expected events then they are not reported by virtue of their not being on the list in the first place.

  • Wed, Oct 06, 2021 - 01:36pm

    #2
    B B

    B B

    Status Bronze Member (Offline)

    Joined: Jun 09 2021

    Posts: 54

    count placeholder17

    Data from Pfizer indicates only 0.18% to 0.36% short term events are reported

In Canada, patients are not allowed to report adverse effects. Only doctors are. Do you think that ER doctors have time for that? Do you think that GPs dare to report it after they have been banned from speaking negatively about vaxx? Most of them want to jab us regardless of the collateral damage anyway, so they don’t want to report the serious side effects.
My 22 year old son has 2 friends who were hospitalized for myocarditis after the vaxx. He doesn’t have 100 000 friends, or a 1000 or even a 100. How is that rare?

  • Wed, Oct 06, 2021 - 01:42pm   (Reply to #2)

    #3
    SDHodges

    SDHodges

    Status Member (Offline)

    Joined: Jun 05 2021

    Posts: 39

    count placeholder5

    Data from Pfizer indicates only 0.18% to 0.36% short term events are reported

Thanks for the input.  All perfectly feasible.  This is an utter disgrace.  My partner works in local government and she reckons from conversations that virtually all staff have been off work for 3 days after either the first or second jab.  My sister in law had covid and the jab and she said the vaccination was far worse than covid.

  • Wed, Oct 06, 2021 - 02:32pm

    #4
    Li

    Li

    Status Member (Offline)

    Joined: Sep 21 2021

    Posts: 10

    count placeholder4

    Data from Pfizer indicates only 0.18% to 0.36% short term events are reported

I’ve noticed that they don’t call fever/chills/headache an “adverse event” they simply call it a side-effect.

  • Wed, Oct 06, 2021 - 02:52pm

    #5
    SDHodges

    SDHodges

    Status Member (Offline)

    Joined: Jun 05 2021

    Posts: 39

    count placeholder2

    Data from Pfizer indicates only 0.18% to 0.36% short term events are reported

I think it makes no difference if you either refer to ‘adverse events’ or ‘side effects’ in any clinical trial.  All should be automatically recorded in whatever monitoring system.

  • Thu, Oct 07, 2021 - 04:38am

    #6
    The Finn

    The Finn

    Status Bronze Member (Offline)

    Joined: Sep 14 2020

    Posts: 70

    count placeholder1

    Data from Pfizer

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

https://www.nejm.org/doi/full/10.1056/NEJMoa2114583?query=featured_home

 

Viewing 6 posts - 1 through 6 (of 6 total)

Login or Register to post comments